Lv1
50 积分 2025-11-07 加入
Integrative single-cell and bulk transcriptome analyses identify a distinct pro-tumor macrophage signature that has a major prognostic impact on glioblastomas
7小时前
待确认
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection
10个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
10个月前
已完结
皖公网安备34019202002308
